116 related articles for article (PubMed ID: 3048796)
1. Luteinizing hormone response to domperidone in hyperprolactinaemic women with pituitary microadenomas.
Seki K; Kato K
Clin Endocrinol (Oxf); 1988 Mar; 28(3):271-5. PubMed ID: 3048796
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
Peters JR; Rodriguez-Arnao MD; Foord SM; Edwards C; Dieguez C; Woodhead S; Hall R; Scanlon MF
J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
5. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
Tay CC; Glasier AF; Illingworth PJ; Baird DT
Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
7. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Seki K; Kato K; Shima K
J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
[TBL] [Abstract][Full Text] [Related]
8. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)].
Bercovici JP; Khoury S; Tater D; Besson G; Caroff J
Biomed Pharmacother; 1983; 37(5):222-7. PubMed ID: 6661508
[TBL] [Abstract][Full Text] [Related]
9. Serum gonadotrophin and sex steroid hormone levels during mid-follicular and mid-luteal phases in hyperprolactinaemic women with regular menstrual cycles.
Nakano R
Br J Obstet Gynaecol; 1987 Feb; 94(2):142-6. PubMed ID: 3103671
[TBL] [Abstract][Full Text] [Related]
10. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
Pohl CR; Weiner RI; Smith MS
Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
[TBL] [Abstract][Full Text] [Related]
11. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Quigley ME; Judd SJ; Gilliland GB; Yen SS
J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
[TBL] [Abstract][Full Text] [Related]
12. Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia.
Seki K; Uesato T; Kato K
Acta Endocrinol (Copenh); 1982 Oct; 101(2):166-70. PubMed ID: 6814135
[TBL] [Abstract][Full Text] [Related]
13. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the prolactin level under the effect of pulsatile infusion of gonadotropin releasing hormone].
Koloszár S; Bártfai G; Sas M
Orv Hetil; 1989 Jul; 130(27):1433-6. PubMed ID: 2501725
[TBL] [Abstract][Full Text] [Related]
15. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
16. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women.
Andersen AN; Tabor A
Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316
[TBL] [Abstract][Full Text] [Related]
17. Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin.
Clayton RN; Bailey LC
J Endocrinol; 1984 Aug; 102(2):215-23. PubMed ID: 6086802
[TBL] [Abstract][Full Text] [Related]
18. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
Nakano R; Yagi S; Nishi T
Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
[TBL] [Abstract][Full Text] [Related]
19. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
20. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
Larrea F; Escorza A; Valencia X; Méndez I; Schiavon R; Forsbach G
Rev Invest Clin; 1991; 43(4):293-8. PubMed ID: 1798861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
